HCBA Lawyer Magazine Vol. 28, No. 3 | Page 37

ConsoLiDation of the oPhthaLMoLogY seCtor Health Care law Section Continued from page 34 Diversified Revenue Base The last factor we focus on, and one critical to the investment thesis, is that the healthcare sector must have a diversified revenue base. More important than diversification of referral sources, although still important, is the diversification of the types of services generating revenue. Of particular importance is the distinction between clinical revenue, which is tied to the number of insureds needing care, and non-clinical revenue, such as retail optical, dry eye clinics, laser cataract technology, among others, that are generally paid out-of- pocket by the patient and offer higher margins than clinical procedures. Moreover, some ophthalmology practices have further diversified their non- clinical offerings into hearing tests as well as dermatology-like ancillary services such as botox, skincare products, and cosmetic surgery. This diversification of the revenue base can offer out- sized margins relative to other sectors and offset risks associated with healthcare reform and political uncertainty. Conclusion The healthcare sectors of dentistry, dermatology, and now ophthalmology all exhibited very similar characteristics to those identified above, which, collectively, create an environment where private equity firms can generate return on investment by capitalizing on the opportunity generated by the complexity of change. Ophthalmology is still in the very early stages of consolidation and offers much opportunity to those aligned with proper counsel and healthcare advisors to address any regulatory hurdles and fair market value issues that arise with each transaction. Author: Alex Kajan, CFA - Intellego Health Health Care Law Section CLE on october 18, katherine Drabiak of the College of Public health at usf gave an overview on emerging cellular and tissue technology and related ethical issues to the health Care Law section. she covered fDa regulations and guidance for integrating product development into clinical practice, as well as considerations for ensuring provider and physician compliance. the section would like to thank its luncheon sponsor: JAN - FEB 2018 | HCBA LAWYER 35